Acute Porphyria Drug Database

Monograph

N07AX01 - Pilocarpine
Propably not porphyrinogenic
PNP

Rationale
Insignificant hepatic metabolic load.
Chemical description
Parasympaticomimetic (tablets 5 or 10 mg x 3) used to increase salivation in postradiation xerostomia and in Sjogrens syndrome. A small part converted to pilocarpinic acid and excreted in urine together with the unchanged substance. Cmax in the ng range. Inhibitor of CYPs 2A6, 3A4, 2E1.

Similar drugs
Explore alternative drugs in similar therapeutic classes N07A / N07AX or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Salagen · Salagen 5 mg filmomhulde tabletten · Salagen 5 mg, filmomhulde tabletten
United Kingdom
Pilocarpine · Pilocarpine 5mg tablets · Pilocarpine hydrochloride 1.25mg/5ml oral solution · Pilocarpine hydrochloride 3mg/5ml oral solution · Pilocarpine hydrochloride 5mg/5ml oral solution · Pilocarpine hydrochloride · Pilocarpine hydrochloride 2.5mg/5ml oral solution · Pilocarpine hydrochloride 8mg/5ml oral solution · Salagen · Salagen 5mg tablets
Norway
Salagen
Finland
Salagen
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙